Literature DB >> 33941447

Human muscle production in vitro from pluripotent stem cells: Basic and clinical applications.

Lu Yan1, Alejandra Rodríguez-delaRosa1, Olivier Pourquié2.   

Abstract

Human pluripotent stem cells (PSCs), which have the capacity to self-renew and differentiate into multiple cell types, offer tremendous therapeutic potential and invaluable flexibility as research tools. Recently, remarkable progress has been made in directing myogenic differentiation of human PSCs. The differentiation strategies, which were inspired by our knowledge of myogenesis in vivo, have provided an important platform for the study of human muscle development and modeling of muscular diseases, as well as a promising source of cells for cell therapy to treat muscular dystrophies. In this review, we summarize the current state of skeletal muscle generation from human PSCs, including transgene-based and transgene-free differentiation protocols, and 3D muscle tissue production through bioengineering approaches. We also highlight their basic and clinical applications, which facilitate the study of human muscle biology and deliver new hope for muscular disease treatment.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Human pluripotent stem cells (PSCs); Muscular dystrophy; Myogenesis; Satellite cells; Skeletal muscle; Tissue engineering

Mesh:

Year:  2021        PMID: 33941447      PMCID: PMC8530835          DOI: 10.1016/j.semcdb.2021.04.017

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  110 in total

1.  Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro.

Authors:  R G Dennis; P E Kosnik
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

2.  Engineering skeletal muscle tissues from murine myoblast progenitor cells and application of electrical stimulation.

Authors:  Daisy W J van der Schaft; Ariane C C van Spreeuwel; Kristel J M Boonen; Marloes L P Langelaan; Carlijn V C Bouten; Frank P T Baaijens
Journal:  J Vis Exp       Date:  2013-03-19       Impact factor: 1.355

3.  ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs.

Authors:  Michael R Hicks; Julia Hiserodt; Katrina Paras; Wakana Fujiwara; Ascia Eskin; Majib Jan; Haibin Xi; Courtney S Young; Denis Evseenko; Stanley F Nelson; Melissa J Spencer; Ben Van Handel; April D Pyle
Journal:  Nat Cell Biol       Date:  2017-12-18       Impact factor: 28.824

4.  HLA engineering of human pluripotent stem cells.

Authors:  Laura Riolobos; Roli K Hirata; Cameron J Turtle; Pei-Rong Wang; German G Gornalusse; Maja Zavajlevski; Stanley R Riddell; David W Russell
Journal:  Mol Ther       Date:  2013-04-30       Impact factor: 11.454

Review 5.  Engineered skeletal muscles for disease modeling and drug discovery.

Authors:  Jason Wang; Alastair Khodabukus; Lingjun Rao; Keith Vandusen; Nadia Abutaleb; Nenad Bursac
Journal:  Biomaterials       Date:  2019-08-08       Impact factor: 12.479

6.  The fate of individual myoblasts after transplantation into muscles of DMD patients.

Authors:  E Gussoni; H M Blau; L M Kunkel
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

7.  Intracellular pH controls WNT downstream of glycolysis in amniote embryos.

Authors:  Masayuki Oginuma; Yukiko Harima; Oscar A Tarazona; Margarete Diaz-Cuadros; Arthur Michaut; Tohru Ishitani; Fengzhu Xiong; Olivier Pourquié
Journal:  Nature       Date:  2020-06-24       Impact factor: 49.962

8.  The molecular basis of muscular dystrophy in the mdx mouse: a point mutation.

Authors:  P Sicinski; Y Geng; A S Ryder-Cook; E A Barnard; M G Darlison; P J Barnard
Journal:  Science       Date:  1989-06-30       Impact factor: 47.728

Review 9.  Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy.

Authors:  Kasia Dzierlega; Toshifumi Yokota
Journal:  Gene Ther       Date:  2020-06-01       Impact factor: 5.250

10.  Myogenic Progenitor Cell Lineage Specification by CRISPR/Cas9-Based Transcriptional Activators.

Authors:  Jennifer B Kwon; Ashish Vankara; Adarsh R Ettyreddy; Joel D Bohning; Charles A Gersbach
Journal:  Stem Cell Reports       Date:  2020-04-23       Impact factor: 7.765

View more
  3 in total

Review 1.  Bioinks and Bioprinting Strategies for Skeletal Muscle Tissue Engineering.

Authors:  Mohamadmahdi Samandari; Jacob Quint; Alejandra Rodríguez-delaRosa; Indranil Sinha; Olivier Pourquié; Ali Tamayol
Journal:  Adv Mater       Date:  2022-02-03       Impact factor: 30.849

2.  Generation of hiPSC-Derived Skeletal Muscle Cells: Exploiting the Potential of Skeletal Muscle-Derived hiPSCs.

Authors:  Eric Metzler; Helena Escobar; Daniele Yumi Sunaga-Franze; Sascha Sauer; Sebastian Diecke; Simone Spuler
Journal:  Biomedicines       Date:  2022-05-23

3.  Tension-driven multi-scale self-organisation in human iPSC-derived muscle fibers.

Authors:  Qiyan Mao; Achyuth Acharya; Alejandra Rodríguez-delaRosa; Fabio Marchiano; Benoit Dehapiot; Ziad Al Tanoury; Jyoti Rao; Margarete Díaz-Cuadros; Arian Mansur; Erica Wagner; Claire Chardes; Vandana Gupta; Pierre-François Lenne; Bianca H Habermann; Olivier Theodoly; Olivier Pourquié; Frank Schnorrer
Journal:  Elife       Date:  2022-08-03       Impact factor: 8.713

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.